ES2034010T3 - Formulacion para la administracion de farmacos por via oral y metodo para prepararla. - Google Patents

Formulacion para la administracion de farmacos por via oral y metodo para prepararla.

Info

Publication number
ES2034010T3
ES2034010T3 ES198888107564T ES88107564T ES2034010T3 ES 2034010 T3 ES2034010 T3 ES 2034010T3 ES 198888107564 T ES198888107564 T ES 198888107564T ES 88107564 T ES88107564 T ES 88107564T ES 2034010 T3 ES2034010 T3 ES 2034010T3
Authority
ES
Spain
Prior art keywords
oral
drug delivery
formulation
compositions
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888107564T
Other languages
English (en)
Inventor
Edward Anthony Newsham
Jeffrey Wilfred Forrester
Duncan John Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21976676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2034010(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of ES2034010T3 publication Critical patent/ES2034010T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTAN SISTEMAS DE LIBERACION QUE INCLUYEN UNO O MAS SOLIDOS HIDROCOLOIDALES , TALES COMO GELATINA, PECTINA Y CARBOXIMETILCELULOSA SODICA, Y PREFERIBLEMENTE MEZCLAS DE ELLOS, CUYOS SOLIDOS CONTIENEN MENOS DEL 5% EN PESO DE HUMEDAD Y PREFERIBLEMENTE COMPRENDEN MENOS DEL 50% EN PESO DE LA FORMULACION TOTAL; Y UNA BASE UNTOSA TAL COMO ACEITE MINERAL QUE CONTIENE POLIETILENO DISPERSADO (PLASTIBASE). ESTAS COMPOSICIONES DE LIBERACION PARA MEDICAMENTOS ORALES PUEDEN USARSE PARA LIBERAR INGREDIENTES ACTIVOS PARA LA MUCOSA ORAL TALES COMO ESTEROIDES, AGENTES ANTIFUNGICOS, AGENTES ANTIBACTERIANOS Y SIMILARES Y NO SE ENDURECEN POR ALMACENAMIENTO PROLONGADO O POR ENVASADO EN RECIPIENTES.
ES198888107564T 1987-05-21 1988-05-11 Formulacion para la administracion de farmacos por via oral y metodo para prepararla. Expired - Lifetime ES2034010T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/052,297 US4867970A (en) 1987-05-21 1987-05-21 Moistureless oral drug delivery formulation and method for preparing same

Publications (1)

Publication Number Publication Date
ES2034010T3 true ES2034010T3 (es) 1993-04-01

Family

ID=21976676

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888107564T Expired - Lifetime ES2034010T3 (es) 1987-05-21 1988-05-11 Formulacion para la administracion de farmacos por via oral y metodo para prepararla.

Country Status (13)

Country Link
US (1) US4867970A (es)
EP (1) EP0291838B1 (es)
JP (1) JPS63303924A (es)
AT (1) ATE79023T1 (es)
AU (1) AU1372888A (es)
CA (1) CA1314479C (es)
DE (1) DE3873410T2 (es)
DK (1) DK278288A (es)
ES (1) ES2034010T3 (es)
GR (1) GR3006146T3 (es)
HU (1) HU199071B (es)
IE (1) IE63548B1 (es)
ZA (1) ZA882290B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
WO1993021905A1 (en) * 1992-04-23 1993-11-11 Berlex Laboratories, Inc. Bioadhesive solid mineral oil emulsion
US5310961A (en) * 1993-07-02 1994-05-10 Affinity Biotech, Inc. Neomorphic ibuprofen
WO1996002275A1 (en) * 1994-07-20 1996-02-01 Toyama Chemical Co., Ltd. Sustained-release oral ointment
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
JP4653282B2 (ja) * 2000-05-23 2011-03-16 昭和薬品化工株式会社 ミノサイクリン含有組成物
TNSN03137A1 (en) 2001-06-22 2005-12-23 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS COMPRISING LOW SOLUBILITY AND / OR ACID SENSITIVE DRUGS AND NEUTRALIZED ACID POLYMERS.
DE10157260B4 (de) * 2001-11-22 2005-12-15 Pharmoxid Arznei Gmbh + Co. Kg Streichfähige Salbe mit Ozoniden und Peroxiden von Fettsäuren oder deren Estern
US20040091551A1 (en) * 2002-11-13 2004-05-13 Al-Karim Damji Topical composition and application system
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
RU2242203C1 (ru) * 2003-08-01 2004-12-20 Губарева Наталия Николаевна Пленочная повязка
RU2242204C1 (ru) * 2003-08-01 2004-12-20 Губарева Наталия Николаевна Атравматичная повязка
JP2005097271A (ja) * 2003-08-20 2005-04-14 Matsumoto Shika Univ 抗真菌剤用組成物
EP1508329A1 (en) * 2003-08-20 2005-02-23 Matsumoto Dental University Composition for an antifungal agent for suppressing fungal growth in an oral cavity
EP1510205B1 (en) * 2003-09-01 2008-03-26 JPM - The Jordanian Pharmaceutical Manufacturing Co. Ltd. Universal controlled-release composition comprising xanthan gum and sodium alginate
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
WO2006031848A2 (en) * 2004-09-15 2006-03-23 Ivax Corporation Corticosteroid topical dispersion with low content of surfactant
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
DK2054031T3 (en) 2006-07-21 2016-05-17 Biodelivery Sciences Int Inc Transmucosal delivery devices with improved uptake
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
AU2012296346A1 (en) 2011-08-18 2014-04-03 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628187A (en) 1950-05-06 1953-02-10 Res Prod Corp Medicinal mineral oil vehicle thickened with polyethylene
US3029187A (en) * 1958-02-20 1962-04-10 Steinhardt Amos Gelating adhesive pharmaceutical preparations
US3029188A (en) * 1958-02-20 1962-04-10 Olin Mathieson Gelatin adhesive pharmaceutical preparations
FR1367858A (fr) * 1962-08-11 1964-07-24 Hoechst Ag Bases de pommades pour les muqueuses et leur préparation
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
GB1063185A (en) * 1965-04-27 1967-03-30 Astra Ab Improvements in the administration of veterinary medicines
US3594467A (en) * 1968-10-09 1971-07-20 Richardson Merrell Inc Long-lasting troche
US3984571A (en) * 1970-03-10 1976-10-05 E. R. Squibb & Sons, Inc. Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
JPS5386011A (en) * 1977-10-31 1978-07-29 Nippon Kayaku Co Ltd Preparation of paste
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
JPS6043328B2 (ja) * 1981-04-16 1985-09-27 昭和薬品化工株式会社 軟膏の基剤
JPS58206534A (ja) * 1982-05-26 1983-12-01 Taisho Pharmaceut Co Ltd 口腔薬基剤
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
EP0256611A1 (en) * 1986-08-08 1988-02-24 Squibb Japan Inc. Oral drug delivery systems

Also Published As

Publication number Publication date
DK278288D0 (da) 1988-05-20
CA1314479C (en) 1993-03-16
DE3873410T2 (de) 1993-01-21
EP0291838B1 (en) 1992-08-05
GR3006146T3 (es) 1993-06-21
EP0291838A2 (en) 1988-11-23
AU1372888A (en) 1988-11-24
ATE79023T1 (de) 1992-08-15
US4867970A (en) 1989-09-19
JPS63303924A (ja) 1988-12-12
DK278288A (da) 1988-11-22
HU199071B (en) 1990-01-29
IE881540L (en) 1988-11-21
DE3873410D1 (de) 1992-09-10
ZA882290B (en) 1988-09-22
IE63548B1 (en) 1995-05-17
HUT49280A (en) 1989-09-28
EP0291838A3 (en) 1989-05-31

Similar Documents

Publication Publication Date Title
ES2034010T3 (es) Formulacion para la administracion de farmacos por via oral y metodo para prepararla.
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
NO2000010I1 (no) Farmasøytisk akseptable salter av esomeprazol
UY23356A1 (es) Preparado para la liberacion retardada de sustancias activas, que son apropiadas como sistema terapeutico o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
ES541521A0 (es) Un procedimiento para la preparacion de piridazinaminas.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
IL74446A (en) Transdermal pharmaceutical compositions for systemic administration containing bopindolol or methysergide
AR012480A1 (es) Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona
HUT57203A (en) Process for substituted benzimidazol and paharmaceutical composition containing them
ATE221372T1 (de) Pharmazeutische zubereitung mit schneller freisetzung
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
DE3783923D1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8522442A0 (it) Derivati nucleosidici aventi proprieta' antierpetiche, composizioni farmaceutiche che licontengono e procedimento per lapreparazione degli ingredienti attivi.
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
IT8222854A0 (it) Derivati dell'acido lattobionico, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 291838

Country of ref document: ES